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Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a benign 
proliferation of the hemophagocytic cells of the monocyte-
macrophage-histiocyte lineage, resulting in the uncon-
trolled phagocytosis of normal hematopoietic cells. 
Clinical severity ranges from complete recovery to rapid 
deterioration and death. Viruses, bacteria, parasites and 
fungi are all reported to be associated with this illness.1,2 
Currently, a diagnosis of HLH requires the fulfillment 
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An association between hemophagocytic lymphohistiocytosis (HLH) and Kikuchi’s disease is rarely seen 
in children. Here, we present the case of a male adolescent (age 16 years and 3 months) who suffered from 
spiking fever for more than 1 week, and multiple nodules over the neck and bilateral axilla for 2 months. 
A skin rash also developed over all four limbs, abdomen and face. Laboratory data and skin biopsy gave 
results compatible with a diagnosis of Kikuchi’s disease. Hemophagocytosis in the bone marrow, hyper-
triglyceridemia, elevated ferritin, and splenomegaly were also found, fulfilling the criteria for HLH. A recent 
primary Epstein-Barr virus infection was also diagnosed by serology. The patient ran a relatively benign 
course. Intravenous immunoglobulins, steroids or etoposide-containing regimens were not used, and his 
recovery was uneventful. A review of the literature showed that up to February 2009, 11 additional cases of 
Kikuchi’s disease presenting simultaneously with, or mimicking, HLH had been reported. Complete reso-
lution within several weeks, with no recurrence, was seen in all but one patient (a pregnant woman).
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of five out of eight clinical and laboratory criteria, which 
include fever, splenomegaly, cytopenia in at least two cell 
lines, hypertriglyceridemia or hypofibrinogenemia, ele-
vated ferritin levels (≥ 500 ng/mL), raised serum soluble 
interleukin (IL)-2 receptor levels (sCD25 ≥ 2,400 U/mL), 
decreased or absent NK-cell activity, and hemophagocy-
tosis in the bone marrow, cerebrospinal fluid or lymph 
nodes.3
Kikuchi’s disease, first reported in Japan independ-
ently by Kikuchi and Fujimoto et al in 1972,3,4 is a well-
defined clinicopathologic entity often seen in young 
adults, and usually follows a benign self-limiting clinical 
course. It is characterized by painful and/or tender cer-
vical lymphadenopathy. It can be accompanied by fever 
and, less commonly, by other symptoms such as a skin 
rash, he patomegaly, and weight loss. Leukopenia is the 
most consistent laboratory finding. The diagnosis of 
Kikuchi’s disease is based on histological findings. The 
pathogenesis is unknown, but a viral cause has long been 
suggested.2
The association of HLH with Kikuchi’s disease is rarely 
reported. Here, we report an adolescent case of Kikuchi’s 
disease associated with HLH caused by primary Epstein-
Barr virus infection. The literature regarding such associ-
ations is also reviewed.
Case Report
A male adolescent (aged 16 years and 3 months) had been 
well until 2 months prior to admission. During this time 
he developed multiple nodules over the right side of his 
neck (2–5 mm in size) without tenderness, local heat, or 
redness, and developed a fever (up to 39.5°C) 6 weeks 
later. Several non-itchy erythematous maculopapular 
rashes developed over all four limbs, abdomen and face. 
He also complained of fatigue, cough, sore throat, and 
shoulder pain. There was no nasal obstruction, nausea, 
vomiting, diarrhea or dysuria, nor a history of animal 
contact. He was admitted to a medical center. Complete 
blood cell counts showed leukopenia, chest radiography 
showed no active lung lesions, and abdominal sonogra-
phy revealed splenomegaly. Bone marrow aspiration was 
negative for malignancy and also negative for bacterial 
cultures. Intravenous ampicillin was given initially, and 
was changed to cefepime on day 5. However, a spiking 
fever still persisted. One week later, at his parents’ request, 
the patient was transferred to Chang Gang Children’s 
Hospital for further investigation and management.
On admission to Chang Gang Children’s Hospital, the 
patient had a high fever (up to 39.6°C). Multiple nodules 
had developed bilaterally on his neck and axillary area. 
Several maculopapular rashes were found on his limbs, 
abdomen and face. Complete blood cell counts showed 
leukopenia (white blood cell count = 1.24 × 109/L neutro-
phils, 61%; lymphocytes 30%; monocytes 8%), a hemo-
globin level of 12.6 g/dL, a platelet count of 130 × 109/L. 
Serum biochemistry showed a C-reactive protein level 
of 17.9 mg/L (normal, < 5 mg/L), aspartate aminotrans-
ferase of 71 IU/L, and alanine aminotransferase of 119 IU/L 
(normal, < 40 IU/L). Because of persistent fever for more 
than 2 weeks, HLH was suspected and further laboratory 
tests were performed. Serum ferritin was 892.9 ng/mL, 
and fasting triglycerides were 275 mg/dL. Rheumatic fac-
tors, C3, C4, antinuclear antibody, and anti-double strain 
DNA were all within normal limits. Bone marrow aspira-
tion (repeated on day 3 post hospitalization), showed re-
active lymphohistiocytes, and hemophagocytosis (Figures 
1A and 1B). A skin biopsy performed at the same time 
showed hyperkeratosis, acanthosis, aggregates of histio-
cytes, crescentic histiocytes, eosinophils, lymphocytes, 
and nuclear dust without granulocytes in the dermis and 
around the adnexae of the skin, which was compatible 
with Kikuchi’s disease (Figure 2). Virological studies were 
positive for anti-Epstein-Barr virus (EBV) capsid IgM, 
anti-EBV capsid IgG (1:160), anti-EB early antigen anti-
body (1:20) and anti-EB nuclear antigen, all of which were 
compatible with a recent primary EBV infection. A cyto-
megalovirus survey and throat swab taken for virus isola-
tion were both negative, as were blood and bone marrow 
cultures for bacteria.
The fever disappeared spontaneously on hospital day 
12 and the patients’ general condition gradually im-
proved. After discussions between the pediatric hematolo-
gist/oncologist, the patient, and his parents, a therapeutic 
regimen for HLH was not initiated. He was discharged on 
day 18. Transient mild fever for several days was noted 
within the first week after discharge, but this later sub-
sided. The size of cervical lymph nodes decreased gradu-
ally and he remained well during followed-up at the 
outpatient department for at least 1.5 years.
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Discussion
In this report, we documented a case of primary EBV-
associated Kikuchi’s disease mimicking HLH. A recent 
primary EBV infection in this patient was confirmed by 
EBV specific serological tests.6 Kikuchi’s disease was con-
firmed by skin biopsy.7,8 HLH was diagnosed by estab-
lished clinical criteria, in which at least five of the eight 
criteria were met: fever for more than 1 week, hypertriglyc-
eridemia, elevated ferritin levels, hemophagocytosis in the 
bone marrow, and splenomegaly. In addition, leukopenia, 
mild anemia and thrombocytopenia were also found. 
Serum soluble IL-2 receptor levels and NK-cell activity 
were not measured.
Up to February 2009, a total of 12 cases mimicking 
HLH presenting simultaneously with Kikuchi’s disease 
had been reported in the literature.9–18 However, only four 
of these cases fulfilled the criteria for HLH (our case and 
other reports8,13,15). Other cases did not fulfill the criteria 
for HLH, but assumed a diagnosis of HLH because hemo-
phagocytosis was found in the bone marrow. Interestingly, 
lymph node hemophagocytosis, which can be seen in 
HLH, was absent in these cases. Of the 12 reported cases, 
nine were children or adolescents (Table 1).7–16 The path-
ogen associated with HLH and Kikuchi’s disease was 
identified in only three cases: respiratory syncytial virus, 
parvovirus B19 and EBV. The case presented here was also 
an adolescent, and primary EBV infection was identified 
at the time of admission.
There were many overlaps in the etiology, clinical 
symptoms and signs between Kikuchi’s disease and HLH 
(Table 2). Findings from our previous reports2,19 and 
those of others20 indicate that lymphadenopathy was the 
most important finding in Kikuchi’s disease, but was also 
found in 68.4% of the childhood cases of HLH. Fever, 
splenomegaly and cytopenia were the diagnostic criteria 
for HLH, but were also found in patients with Kikuchi’s 
disease, especially in those with prolonged fever.2,19,20 
Hence, Kelly et al thought that HLH and Kikuchi’s disease 
may be two stages of a disease continuum, rather than 
different entities.14
Childhood HLH, if associated with EBV infection, 
runs a relatively severe and potentially fatal course.19–21 
Figure 1. Bone marrow aspirate showed (A) abnormal lymphohistiocytes and (B) hemophagocytosis. (Giemsa stain; original magnifi-
cation, 1,000˜).
A B
Figure 2. Skin biopsy showed periadnexal infiltration of histiocytes 
admixed with nuclear dust (arrow) (Original magnification, 200×).
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Kikuchi’s disease is usually self-limiting,2 and supportive 
treatment alone may be sufficient. Combination therapy 
with intravenous immunoglobulins and steroids is the 
treatment of choice for HLH, and etoposide-containing 
regimens are reserved for those who fail to respond to 
the combination therapy.19,22 However, intravenous im-
munoglobulin, steroids or etoposide-containing regi-
mens were not used in this patient, and the patient 
recovered uneventfully. All 12 patients with concomitant 
Kikuchi’s disease and mimicking hemophagocytic lym-
phohistiocytosis shown in Table 1 had complete resolu-
tion of disease within several weeks with no re currence, 
except for one patient who is a pregnant woman. Our case 
indicates that primary EBV infection with Kikuchi’s dis-
ease may progress to HLH, and the prognosis is not al-
ways poor.
Table 1. Cases of concomitant Kikuchi’s disease and those mimicking hemophagocytic lymphohistiocytosis reported in the literature
 Age (yr)/    Year
Case
 sex 
Virus Therapy Outcome
 [Reference]
 1 15/F Parvovirus  Prednisolone (60 mg/d) Clinical symptoms resolved 1997 [7]
  B19  within 3 wk; cytopenia
    normalized within 2 mo
 2 37/F – Methylprednisolone Clinical symptoms resolved 2000 [8]
   pulse therapy (1 g for 3 d) within 2 wk
 3 4/M RSV Prednisolone, etoposide,  Rapid resolution of 2000 [9]
   cyclosporine A symptoms and remains well.
 4 10/F – IVIG (1 g/kg/day for 2 d),  Dramatic response, no recurrence 2000 [10]
   prednisolone (2 mg/kg/day)
 5 14/M – IVIG (1 g/kg/day for 2 d),  Improved gradually after administration 2000 [10]
   prednisolone (2 mg/kg/day) of prednisolone, no recurrence
 6 24/F EBV  IVIG 60 g for 3 d, acyclovir Postpartum death 2000 [11]
   750 mg IV every 12 hr
 7 17/F – IVIG Complete continuous response to therapy 2000 [11]
 8 1/F – IVIG 2 g/kg, methylprednisolone Made a good recovery on cyclosporin 2003 [12]
   (20 mg/kg) followed by oral and is currently in remission with
   prednisolone 1 mg/kg/day,  no systemic features or joint problems
   methotrexate, cyclosporine
   (3 mg/kg/day)
 9 13/F – IVIG (0.4 g/kg/day for 5 d) and  Complete resolution within 2003 [2]
   methylprednisolone (1 g/d for 3 d),  1.5 mo and no evidence of disease
   etoposide (150 mg/m2), oral recurrence during the following 8 mo
   dexamethasone and
   trimethoprim/sulfamethoxazole
10 2/M – Prednisolone (2 mg/kg) Good response on treatment of 2006 [15]
    autoimmune-phenomena with prednisolone,
    but death due to transplant failure for
    juvenile myelomonocytic leukemia
11 40/M – Naproxen 500 mg twice daily po Fever and lymphadenopathy subsided 2007 [16]
    after 10 d
12 16/M EBV No IVIG or steroid Improved gradually,  Present 
    no recurrence study
RSV = Respiratory syncytial virus; EBV = Epstein-Barr virus; IVIG = intravenous immunoglobulin; IV = intravenous; po = orally.
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Table 2. Comparison of Kikuchi’s disease and hemophagocytic lymphohistiocytosisa
 Kikuchi’s disease (n = 64) [2] HLH (n = 18/19) [19,22]
Prolonged fever  32.8 100
Splenomegaly 7.8/23.8b 61.1–94.7
Lymphadenopathy  98.4 44.4–68.4
Skin rash  6.3 55.6–57.9
Leukopenia (WBC < 4.0 × 109/L) 44.1/61.9b 50.0
Anemia (Hb < 10 mg/dL) 3.4/10.0b 84.2
Thrombocytopenia    9.3c  55.6–78.9d
Elevated liver enzyme (AST or ALT > 45 IU/L) 25.0/37.5b 83.3–89.5
aData presented as %; bin patients with prolonged fever; cplatelet < 150 × 109/L; dplatelet < 100 × 109/L. WBC = white blood cell; Hb = hemoglobin; 
AST = aspartate aminotransferase; ALT = alanine aminotranferease; HLH = hemophagocytic lymphohistiocytosis.
